Clinical Specialties

High-Speed Molecular Diagnostics for Hospitals & Inpatients

Hospitalized patients require rapid, reliable diagnostics to guide treatment decisions, prevent deterioration, and reduce length of stay. Chronetyx delivers advanced molecular testing with industry-leading turn-around-times, high automation, and integrated reporting — purpose-built for inpatient care, emergency departments, and hospital outpatient departments.

We provide next-day results across our full menu of infection-related molecular tests:

• Respiratory PCR
• Urine PCR (UTI) (with Antibiotic Resistance Detection)
• Wound PCR (with Antibiotic Resistance Detection)
• STI PCR
• Solid Tumor NGS (CYX Solid Tumor 505) – result within a week

All testing is performed on our fully automated molecular platform, eliminating manual variability and ensuring consistent, high-quality results.

Why Hospitals Partner With Chronetyx

Rapid Turnaround to Improve Patient Outcomes

Most PCR-based results return within a day — significantly faster than typical reference lab timelines — supporting early intervention and reducing delays in care.

Supports Emergency Department & Inpatient Efficiency

Rapid infectious disease results help reduce unnecessary admissions, streamline triage, and lower bed utilization.

High Sensitivity for Compromised or Complex Patients

PCR identifies low-abundance pathogens and polymicrobial infections, which can be missed by culture — critical for immunocompromised, oncology, ICU, and surgical patients.

Accurate Even After Antibiotics

Traditional culture fails after empiric antibiotic therapy begins. PCR remains effective, ensuring clinicians get accurate answers even in pre-treated patients.

Built-In Antibiotic Resistance Detection

UTI and Wound Panels automatically reflex to antibiotic resistance gene detection when pathogens are present, supporting stewardship programs and targeted therapy.

Automation = Fewer Errors, Better Consistency

Robotic sample processing eliminates manual pipetting errors and greatly reduces quality issues.

Seamless EHR Integration

Results delivered via HL7, secure FTP, or directly through our clinician portal -CLEO – designed for inpatient workflows.

Competitive Pricing

Advanced molecular accuracy at the same cost footprint as traditional Culture & Sensitivity.

Hospital Testing Menu

Respiratory PCR Panel

One swab detects 16 common upper-respiratory pathogens relevant to inpatient and emergency department care.

Includes SARS-CoV-2, Flu A/B, RSV, Human metapneumovirus, Parainfluenza, Mycoplasma pneumoniae, and more.

Benefits:

• Rapid clarity for febrile patients
• Distinguishes viral vs. bacterial infection
• Avoids unnecessary broad-spectrum antibiotics
• Supports isolation decisions & infection control

Urine PCR (UTI) Panel

Precision UTI diagnostics for inpatients, emergency department patients, and postoperative patients.

Detects common uropathogens and reflexes to antibiotic resistance gene testing when present.

Ideal for:

• Elderly patients
• Catheter-associated UTIs
• Post-surgical infections
• Immunocompromised patients
• Difficult or recurrent infections

Benefits:

• Accurate even with prior antibiotic exposure
• Eliminates “mixed flora” ambiguity
• Reduces repeat testing & delays in therapy

Wound PCR Panel

Fast identification for chronic wounds, surgical-site infections, and device-associated infections.

Detects polymicrobial infections and antibiotic resistance genes up to 5 days faster than culture.

Applications:

• Postoperative infections
• Diabetic foot ulcers
• Pressure injuries
• Vascular surgery wound concerns

Benefits:

• Earlier targeted therapy
• Reduced length of stay and readmissions
• Improves wound care outcomes

STI PCR Panel

High-sensitivity screening for emergency department and inpatient evaluations.

Detects Chlamydia, Gonorrhea, Trichomonas, and Mycoplasma genitalium.

Benefits:

• Rapid clarity during pelvic pain or dysuria workups
• Non-invasive urine-based testing
• Supports partner management and public health reporting

Solid Tumor NGS (Cyx Solid Tumor 505)

Comprehensive genomic profiling for oncology inpatients and surgical pathology.

Identifies actionable biomarkers including MSI, TMB, SNVs, indels, amplifications, and translocations.

Benefits:

• Fast turnaround (within a week) to guide therapy
• FDA-cleared detection chemistry
• Appropriate for 35+ tumor types
• Ideal for inpatient oncology, pathology, or tumor boards

Designed for Hospital Workflows

Free Logistics Support

• FREE local courier for Memphis-area hospitals
• FREE FedEx shipping for regional clients
• Pre-labeled kits included

High-Capacity Automation

We support high test volumes, hospital surge periods, and seasonal demand spikes.